Evalation of the contribution of SMN1 and SMN2 sequence variants to the clinical severity of SMA
Principal investigator(s) :
Dr. Kathleen MahiasInstitution :
INSERM, Lille, FranceGrant :
€55,500Grant Type:
Operating GrantCall number :
3Start year :
2011Duration :
2 yearsStatus :
Ended